Notably no cleaved forms of Trop-2 were detected, just as in human samples, indicating in vivo reliable assessment of discrimination between cancer-activated Trop-2 and uncleaved, low-to-nil binding Trop-2 structure. This evidence concerns the gene TACSTD2 and cancer.